Environmental Science and Pollution Research, 27 (35), 4419544204
Clinicians should follow standard clinical pathways for investigating pelvic symptoms, regardless of whether the patient is taking Wegovy
Efficacy of the neurokinin-1 receptor antagonist aprepitant in children with cyclical vomiting syndrome
32, 33 Although numerous stimulants can affect PSCs including activation of some G-protein-coupled receptors (PGE2, angiotensin, CCK-A, CCK-B), 34, 35, 36, 37, 38, 39 it is unknown if GLP-1R occurs on PSC either in normal pancreas or pancreatic disease states or, whether PSCs are activated in AP or CP, or if it does occur, whether the GLP-1R agonists affect the PSC signaling cascade, growth or ability to release inflammatory mediators
The answer to this is, of course, no you are not going to turn any darker than you are naturally